RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. The company is headquartered in Aliso Viejo, California and currently employs 461 full-time employees. The company went IPO on 2021-07-30. Its RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system is composed of RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and related accessories. The LAL is an intraocular lens (IOL) made from the silicone-based photosensitive material that undergoes controlled changes in refractive power when exposed to specific ultraviolet (UV) light patterns generated by the LDD. Its LAL uses a silicone formulation that enables changing the mechanical and optical properties of the lens following implantation. The LDD uses software and algorithms to deliver a short UV light exposure treatment that polymerizes specific portions of the lens and allows doctors to adjust spherical and cylindrical refraction.
Dr. Ron Kurtz est le President de Rxsight Inc, il a rejoint l'entreprise depuis 2016.
Quelle est la performance du prix de l'action RXST ?
Le prix actuel de RXST est de $6.08, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Rxsight Inc ?
Rxsight Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Rxsight Inc ?
La capitalisation boursière actuelle de Rxsight Inc est de $251.1M
Est-ce que Rxsight Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 10 analystes ont établi des notations d'analystes pour Rxsight Inc, y compris 0 achat fort, 1 achat, 10 maintien, 3 vente et 0 vente forte
